News Release

LIST

  1. May 11, 2018

    Business

    Announcement of Phase 2 trial results of Imarikiren (SCO-272) at the 55th ERA-EDTA CONGRESS236 KB

  2. January 19, 2018

    Business

    Pipeline Portfolio has been updated.

  3. October 27, 2017

    Business

    Announcement of Phase 1 study results of Imarikiren (SCO-272) at the 38th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics383 KB

  1.